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Abstract
Background: Procedures for the clinical assessment of acute poisoning by substances of abuse should identify
patients in need of hospital admission and avoid hazardous discharges, while keeping the observation time short.
We assess the safety of a systematic procedure developed at the Oslo Accident and Emergency Outpatient Clinic
(OAEOC).
Methods: All patients 12 years and older treated for acute poisoning by substances of abuse at the OAEOC were
included consecutively from October 2011 to September 2012. Data were collected on pre-set registration forms.
Information on re-presentations to health services nation-wide during the first week following discharge was
retrieved from the Norwegian Patient Register and from local electronic medical records. Information on fatalities
was obtained from the Norwegian Cause of Death Registry.
Results: There were 2343 cases of acute poisoning by substances of abuse. The main toxic agent was ethanol in
1291 (55 %) cases, opioids in 539 (23 %), benzodiazepines in 194 (8 %), central stimulants in 132 (6 %), and
gamma-hydroxybutyrate (GHB) in 105 (4 %). Median observation time was four hours. The patient was hospitalised in
391 (17 %) cases. Two patients died during the first week following discharge, both from a new opioid poisoning.
Among 1952 discharges, 375 (19 %) patients re-presented at the OAEOC or a hospital within a week; 13 (0.7 %)
with a diagnosis missed at the index episode, 169 (9 %) with a new poisoning, 31 (2 %) for follow-up of concomitant
conditions diagnosed at index, and 162 (8 %) for unrelated events. Among the patients with missed diagnoses, five
needed further treatment for the same poisoning episode, two were admitted with psychosis, one had hemorrhagic
gastritis, another had fractures in need of surgery and four had minor injuries.
Conclusion: The procedure in use at the OAEOC can be considered safe and could be implemented elsewhere. The
high re-presentation rate calls for better follow-up.
Keywords: Alcohol, Opioids, Benzodiazepines, Central stimulants, GHB, Triage
Background
Patients with self-inflicted poisoning often need hours
of observation in emergency departments and are fre-
quently admitted to hospital [1–3]. Many of these
poisonings are by substances of abuse. Mostly, they
are accidental overdoses of ethanol or drugs taken for
purposes of intoxication or recreation. Some are sui-
cide attempts [4, 5]. To identify the patients in need
of hospital admission, keeping the observation time
short, but long enough to avoid hazardous discharges,
would be cost efficient and would help avoid crowding in
emergency departments. Procedures have been suggested
for different groups of poisoned patients [6–8].
The Oslo Accident and Emergency Outpatient Clinic
(OAEOC), in Oslo, Norway, has for decades used a sys-
tematic clinical procedure for the assessment of patients
presenting with suspected poisoning by substances of
abuse [9]. This procedure is designed to enable the phys-
ician to identify patients in need of more intensive care
than mere observation, and to identify conditions
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mimicking poisoning. The procedure demands less la-
boratory investigations than routinely are done in hos-
pital emergency departments. Though not suitable for
acute poisoning in general, the procedure could simplify
management of patients with suspected poisoning by
substances of abuse in hospital emergency departments.
In 2008, only 14 % of the 1714 patients treated for acci-
dental overdose with substances of abuse at the OAEOC
were hospitalised [10]. Previous studies have shown that
the procedure seems safe considering short-term mor-
tality [10, 11]. However, no studies have addressed
whether serious non-fatal conditions are overlooked
among the patients discharged.
Objectives
Our main aim was to assess the safety of the procedure
in use at the OAEOC for treatment of acute poisoning
by substances of abuse through charting mortality, cause
of death and diagnosis at re-presentations to the
OAEOC or any Norwegian hospital, within the first
week following discharge from the OAEOC.
Further aims were to describe the acute poisonings by
substances of abuse treated at the OAEOC and to iden-
tify factors associated with hospitalisation.
Methods
The study was a prospective observational cohort study.
The epidemiological results from the study have been
published elsewhere [12].
Setting
The Norwegian emergency care system has two levels.
Patients cannot present directly to hospitals, but have to
be assessed in primary care or by the ambulance service
first. Primary care emergency services are provided by
regular general practitioners during office hours and by
local casualty clinics during nights and weekends. The
OAEOC is the main casualty clinic in Oslo, serving the
entire city at all hours. It is a combined emergency gen-
eral practice service and trauma clinic, with limited diag-
nostic resources and observation capacity. It has about
200 000 consultations a year. The physicians are mostly
registrars. It also contains a psychiatric emergency ser-
vice, a 24-h observation unit and emergency social ser-
vices. In most Norwegian cities, patients with acute
poisoning by substances of abuse are treated in hospitals,
but in Oslo the majority are treated at the Department
of Emergency General Practice at the OAEOC [10–12].
Other casualty clinics in Oslo do not treat patients with
acute poisoning to any significant extent. Oslo is the
capital city of Norway and had a population of 613 285
as per 1 January 2012 [13].
The procedure in use at the OAEOC for the clinical
assessment of patients presenting with suspected acute
poisoning by substances of abuse was developed lo-
cally in the 1980s. It has regularly been revised. It
consists of a basic clinical examination including vital
signs, Glasgow Coma Scale (GCS) score and measure-
ment of blood sugar level and peripheral capillary
oxygen saturation (SpO2). The physician decides
whether the patient should be hospitalised, observed
at the OAEOC or discharged, based on standardised
minimum clinical data gathered on an observational
chart (Table 1). All patients presenting to the OAEOC
are triaged using the Manchester Triage System
(MTS), which gives the patients a priority for how
soon a physician should see them [14]. After triage,
patients with suspected acute poisoning by substances
of abuse are examined and observed according to the
observational chart. An assigned nurse observes the
patient every 15–30 min. No toxicological screening
tests are used, apart from breath analysis of ethanol.
Point of care tests for haemoglobin, C-reactive protein
and urine stick are available, as are electrocardiograms,
CT head scans and regular X-rays. Blood gas levels are
not measured. The main criterion for hospitalisation is
finding a condition requiring acute medical or psychiatric
care at hospital level. If the respiratory rate falls below ten
per minute and SpO2 falls below 90 %, antidote
should be given when opioid or benzodiazepine poi-
soning is suspected. When naloxone is administered,
the patient should be observed for two hours in case
of heroin poisoning, or hospitalised in case of long
acting opioids. Patients with benzodiazepine poisoning
in need of flumazenil should be hospitalised. Patients
with respiratory depression caused by agents with no
antidote or not responding to antidote should be hospita-
lised. Patients with suspected gamma-hydroxybutyrate
(GHB) poisoning are often in a condition considered too
unstable for observation at the OAEOC, with level of con-
sciousness fluctuating from coma to agitation in need of
sedation. Hence, the threshold for hospitalising these pa-
tients is low. Patients with hyperthermia due to central
stimulant poisoning should be hospitalised, as should pa-
tients with psychosis. At the time of the study, comatose
patients with a GCS score > 3, normal vital signs and
nothing alarming on the minimum clinical examination
were observed locally. The GCS threshold was later raised
to a score > 6, based on the work of Forsberg et al. [15]. In
either case, patients should be hospitalised if their level of
consciousness is declining, or if they fail to regain con-
sciousness within four hours. The maxim of the procedure
is that conditions in need of treatment will show up in the
clinical examination dictated by the observational chart.
Inclusion
All patients 12 years and older treated at the OAEOC
for acute poisoning in which the main toxic agent was
Vallersnes et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2016) 24:76 Page 2 of 10
suspected to be a substance of abuse were included, irre-
spective of the intention behind the poisoning. All po-
tential substances of abuse were included, encompassing
alcohol, prescription drugs, illegal drugs and others. Pa-
tients treated for multiple conditions were included if
the poisoning was serious enough to warrant treatment
or observation. The period of inclusion was 1 year, from
1 October 2011 to 30 September 2012, to take seasonal
variations into account. The physicians included patients
consecutively. We regularly and systematically searched
the patient lists in the electronic medical records and in-
cluded any missed eligible patients.
Participants
In total, 3139 cases of acute poisoning were registered.
In 216 cases, the patient declined participation. In 406
cases, the suspected main toxic agent was not a sub-
stance of abuse, and the patient was excluded. Further-
more, in 174 cases, the patient did not have a Norwegian
national identity number and was excluded, leaving 2343
included cases in 1731 patients.
Data collection
Data were collected on registration forms and observa-
tional charts completed by the physicians and nurses
treating the patients. We collected any missing informa-
tion from the electronic medical records, along with data
for patients included in the patient list searches.
Patients were identifiable by their unique Norwegian
national identity number. Data on presentations to any
Norwegian hospital during the first week following dis-
charge from the OAEOC were retrieved from the
Norwegian Patient Register (NPR), as were data con-
cerning the hospital treatment of patients hospitalised
from the OAEOC. The NPR registers all patient con-
tacts in Norwegian hospitals and specialist health ser-
vices. Data on fatalities and cause of death were
obtained from the Norwegian Cause of Death Regis-
try. Diagnoses were given as codes in the Inter-
national Classification of Diseases and Related Health
Problems 10th Edition (ICD-10). Data on new presenta-
tions at the OAEOC during the first week were gathered
from the local electronic medical records.
Outcome measures
The main outcome measures were fatalities and re-
presentations to the OAEOC or any Norwegian hospital
during the first week following discharge from the
OAEOC. Time from discharge to re-presentation or
death was calculated. Level of care and length of hospital
stay were registered. Reason for re-presentation was
categorised as missed diagnosis (including further treat-
ment of the same poisoning), new poisoning, follow-up
of concomitant condition diagnosed at index, and unre-
lated event. The categorisation was based on case notes
in the electronic medical records at the OAEOC, and on
diagnoses obtained from the NPR and the Norwegian
Cause of Death Registry.
Additional measures were time and mode of presen-
tation to the OAEOC, disposition and time of discharge,
age, gender, toxic agents, reason for hospitalisation (more




Date and time of presentation
Who brought the patient?
From where was the patient brought?
Substances of abuse taken
Time when taken
Quantity taken




Serious psychiatric disorder (yes/no)
Known substance use (alcohol/opioids/other/none)












Other information (free text)
During observation time (fields provided for repeated observations)
Glasgow Coma Scale score
Pupil reaction to light (+/+)
Respiratory rate
SpO2
Symmetric movement of arms and legs
Medication given
In ambulance
At the casualty clinic
The clinical assessment of acute poisoning by substances of abuse at the Oslo
Accident and Emergency Outpatient Clinic is based on standardised minimum
clinical data gathered on a pre-set observational chart
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than one could be given), and the intention behind
the poisoning. The physicians categorised intention as
accidental overdose with substances of abuse, suicide
attempt or mere accident/not self-inflicted. Poisonings
with any degree of suicidal motivation or intentional
self-harm were categorised as suicide attempts. The
physicians diagnosed toxic agents based on all avail-
able information. The main toxic agent was defined
as the one considered most toxic in the doses taken.
Toxic agents were categorised as ethanol, opioids,
benzodiazepines, central stimulants, GHB and other
substances of abuse. Z-drugs were classified as benzo-
diazepines. Clinical observations included highest and
lowest respiratory rate, lowest SpO2, lowest GCS
score, heart rate, blood pressure, temperature, blood
glucose level, track marks, external signs of injury,
pupil reaction to light, nystagmus, plantar reflexes
and symmetric movement of limbs. Breath analyser
results, if available, were gathered from the patients’
electronic medical records. Any concomitant condi-
tions and complications were registered by the phys-
ician treating the patient, along with medication given
during observation or by ambulance personnel before
arriving at the OAEOC, whether a CT head scan was
done, and any involvement of other departments at
the OAEOC. For hospitalised patients, we registered
diagnoses at hospital and length of hospital stay.
Statistics
Analyses were done in IBM SPSS version 21 (IBM
Corp.). Mann–Whitney U-test was used when com-
paring continuous variables. Chi-square test was used
to compare frequencies. Logistic regression analysis
was used to estimate odds ratios for factors associated
with hospitalisation. Relevant variables were first ana-
lysed one by one. The variables analysed were age,
gender, main toxic agent, number of toxic agents,
intention, naloxone treatment, clinical observations,
complications and concomitant conditions. Ethanol
was chosen as the reference group when estimating
odds ratios for main toxic agents, as it was the largest
group. Factors associated with hospitalisation in the
univariate analyses with a significance level of p < 0.10,
were included in the multivariate model.
Ethics
The study was performed in accordance with the
Helsinki declaration and approved by the Regional
Committee South East for Medical and Health Re-
search Ethics (REK nr 2010/1129-1) and the Oslo
University Hospital Information Security and Privacy
Office. Patients were included after having provided
verbal consent.
Results
There were 2343 cases of acute poisoning by substances
of abuse included during 1 year, 1600 (68 %) were in
males. Median age was 39 years among males and
30 years among females. The most frequent toxic agents
were ethanol in 1291 (55 %) cases and opioids in 539
(23 %) (Table 2). In 761 (32 %) cases there were more
than one toxic agent (range 1–5). Most poisonings, 2158
(92 %), were accidental overdoses with substances of
abuse, 139 (6 %) were suicide attempts.
Two patients died within the first week following dis-
charge, both from a new poisoning. One died from an
unintentional heroin overdose at least 16 h after being
discharged to the Emergency Social Services after five
hours of observation for a possible suicide attempt with
heroin, benzodiazepines and anabolic steroids. The other
died from an unintentional methadone overdose the 5th
day, having self-discharged after nine hours of observa-
tion for an accidental overdose with buprenorphine and
benzodiazepines which was treated with naloxone
0.4 mg intramuscularly shortly after presentation.
In 1952 (83 %) cases, the patient was discharged.
Among them, 375 (19 %) re-presented at the OAEOC or
a hospital during the first week following discharge
(Fig. 1); 13 (0.7 %) with a diagnosis missed at the index
episode, 169 (9 %) with a new poisoning, 31 (2 %) for
follow-up consultations concerning concomitant condi-
tions diagnosed at index, and 162 (8 %) for reasons not
related to the index episode. The age range of patients
with missed diagnoses was 14–49 years, and 9/13 (69 %)
were males (Table 3). Among the re-presenting patients,
88/375 (23 %) had self-discharged. Among the patients
re-presenting with a new poisoning, 46/169 (27 %) had
self-discharged.
The patient was brought by ambulance in 1431 (61 %)
cases, by the police in 393 (17 %), by addiction outreach
services in 96 (4 %), by companions in 141 (6 %), by
others in 86 (4 %), and presented on their own in 196
(8 %) cases. Clinical observations, complications and
concomitant conditions are shown in Table 2. A CT
scan was done in 144/217 (66 %) patients with con-
comitant head injury, eight were positive. Medical
treatment was given in 402 (17 %) cases (Table 4).
Naloxone was given in 198 (8 %) cases; intramuscu-
larly in 123/198 (62 %), intravenously in 6/198 (3 %),
and both in 51/198 (26 %). Naloxone was given by
the ambulance service in 138/198 (70 %) cases, at the
OAEOC in 45/198 (23 %), and both in 15/198 (8 %).
Mean number of doses was 1.4 (range 1–4), mean
total dose was 0.8 mg (range 0.2–2.4). No patients
died at the OAEOC.
In 391 (17 %) cases the patient was hospitalised; 321/391
(82 %) to medical departments, 23/391 (6 %) to other som-
atic departments, and 49/391 (13 %) to psychiatric wards.
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Table 2 Factors associated with hospitalisation—logistic regression analysisa
n (%) Hospitalised n (%) Crude Adjusted
Odds ratio 95 % CI p Odds ratio 95 % CI p
Age
26–50 yearsb 1207 (52) 245 (20)
≤ 25 years 640 (27) 78 (12) 0.55 0.41–0.72 <0.001 0.75 0.53–1.0 0.090
> 50 years 496 (21) 68 (14) 0.62 0.47–0.84 0.002 1.2 0.83–1.7 0.348
Gender
Malesb 1600 (68) 288 (18)
Females 743 (32) 103 (14) 0.73 0.57–0.94 0.013 0.74 0.55–1.0 0.052
Main toxic agent
Ethanolb 1291 (55) 103 (8)
Opioids 539 (23) 102 (19) 2.7 2.0–3.6 <0.001 1.7 1.1–2.5 0.014
Benzodiazepines 194 (8) 65 (34) 5.8 4.1–8.3 <0.001 3.6 2.2–5.8 <0.001
Central stimulants 132 (6) 42 (32) 5.4 3.5–8.2 <0.001 2.5 1.4–4.5 0.001
GHB 105 (4) 60 (57) 15.4 9.9–23.8 <0.001 19.0 11.3–32.0 <0.001
Other/Unknown 82 (3) 19 (23) 3.5 2.0–6.0 <0.001 2.1 1.1–4.2 0.026
Number of toxic agents 1.3 1.2–1.5 <0.001 0.89 0.75–1.1 0.204
Suicide attemptc 139 (6) 61 (44) 4.4 3.1–6.3 <0.001 6.9 4.2–11.4 <0.001
Treatment with naloxonec 198 (8) 48 (24) 1.7 1.2–2.4 0.003 1.1 0.72–1.8 0.581
Clinical observationsc
Respiratory depressiond 287 (12) 86 (30) 2.5 1.9–3.3 <0.001 2.4 1.7–3.5 <0.001
Respiratory rate > 20/min 304 (13) 61 (20) 1.3 0.96–1.8 0.091 1.2 0.79–1.7 0.469
Heart rate≥ 100/min 430 (18) 104 (24) 1.8 1.4–2.3 <0.001 1.7 1.2–2.4 0.002
Temperature≥ 39.0 °C 11 (<1) 8 (73) 13.6 3.6–51.4 <0.001 1.8 0.34–9.3 0.503
Glucose≤ 3.0 mmol/L 12 (1) 6 (50) 5.1 1.6–15.8 0.005 6.5 1.8–23.7 0.005
Neurological signse 62 (3) 22 (35) 2.9 1.7–4.9 <0.001 3.9 2.1–7.3 <0.001
Hallucinations 59 (3) 31 (53) 5.9 3.5–10.0 <0.001 9.6 5.0–18.5 <0.001
Chest painc 24 (1) 9 (38) 3.0 1.3–7.0 0.009 5.6 2.2–14.6 <0.001
Head injuryc 217 (9) 24 (11) 0.60 0.38–0.92 0.021 0.97 0.59–1.6 0.888
Seizuresc 42 (2) 17 (40) 3.5 1.9–6.6 <0.001 5.7 2.7–12.1 <0.001
Infectionc 64 (3) 31 (48) 5.0 3.0–8.3 <0.001 6.3 3.5–11.3 <0.001
Other complicationsc 145 (6) 58 (40) 3.7 2.6–5.3 <0.001 6.5 4.2–10.0 <0.001
Lowest GCS scoref
15b 680 (29) 85 (13)
10–14 1316 (56) 208 (16) 1.3 1.0–1.7 0.048 2.0 1.4–2.8 <0.001
8–9 223 (10) 49 (22) 2.0 1.3–2.9 0.001 3.0 1.8–4.9 <0.001
≤ 7 113 (5) 41 (36) 4.0 2.6–6.2 <0.001 6.5 3.7–11.6 <0.001
Total 2343 (100) 391 (17)
Adjusted odds ratios for significant associations are shown in bold types
CI confidence interval, GCS Glasgow coma scale, GHB gamma-hydroxybutyrate
a In the univariate analyses, the following variables were not significantly associated with hospitalisation (p ≥ 0.10): systolic blood pressure ≥180 (n = 12, 4 (33 %)
admitted); systolic blood pressure ≤ 90 (n = 117, 21 (8 %) admitted); temperature ≤ 34.0 °C (n = 34, 8 (23 %) admitted); glucose ≥ 14.0 mmol/L (n = 19, 5 (26 %)
admitted); track marks (n = 375, 60 (16 %) admitted); other injuries (n = 171, 29 (17 %) admitted); and breath analysis alcohol level (analysed in 805 (34 %)
patients, median 190 mg/dL in hospitalised patients, 210 mg/dL in discharged patients)
b Reference group
c The reference groups are not suicide attempt/no treatment with naloxone/observation or complication not recorded (reference groups not shown)
d Respiratory rate < 10/min, SpO2 < 90 %, or in need of respiratory support
e Comprises nystagmus, inverted plantar reflex, asymmetric pupil reaction to light or asymmetric movement of limbs
f Eleven cases missing
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The factors most strongly associated with hospitalisation
were GHB poisoning (adjusted odds ratio (AOR) 19.0,
95 % confidence interval (CI) 11.3–32.0), hallucinations
(AOR 9.6, 95 % CI 5.0–18.5), suicide attempt (AOR 6.9,
95 % CI 4.2–11.4), hypoglycaemia (AOR 6.5, 95 % CI
1.8–23.7), and GCS score ≤ 7 (AOR 6.5, 95 % CI 3.7–11.6)
(Table 2). Median observation time at the OAEOC was
3 h 55 min (interquartile range (IQR) 2 h 10 min–5 h
20 min), but significantly shorter for patients hospitalised,
median 1 h 50 min (IQR 1 h 00 min–4 h 10 min), than for
patients discharged from the OAEOC, median 4 h 15 min
(IQR 2 h 35 min–5 h 25 min) (p < 0.001). Hospitalisation
of patients with GHB poisoning, low GCS score or hyper-
thermia occurred early, while hospitalisation of patients
with hypoglycaemia or infection occurred late. The main
reason for hospitalisation was the poisoning itself in 206
(53 %) cases, and unclarified condition in 113 (29 %) cases
(Table 5). Median length of hospital stay was 1 day (IQR
0–2, range 0–191), 129 patients (33 %) stayed more than
24 h. One patient with ethanol poisoning, resuscitated at
the OAEOC after cardiac arrest subsequent to aspiration
during transport, died from respiratory failure due to
pneumonitis after 25 days in hospital.
The patients who declined participation did not sig-
nificantly differ in age (p = 0.81) or gender (p = 0.75)
from the rest. In the 174 cases excluded due to lack of a
Norwegian national identity number, the patients were
younger (median age 27, p < 0.001) and more often male
(81 %, p = 0.001) than in the included cases. There were
no significant differences in main toxic agents (p-values
ranging from 0.064 to 0.56), apart from a smaller pro-
portion of central stimulants (2 %, p = 0.042). There
were no significant differences in intention (p = 0.18),
observation time (p = 0.50) or proportion hospitalised
(p = 1.00). Apart from larger proportions with low
GCS scores (11 % with GCS ≤ 7, p = 0.001, and 20 %
with GCS 8–9, p < 0.001) and tachypnoe (21 %, p = 0.006),
there were no significant differences in the clinical
measures listed in Table 2 (p-values ranging from
0.11 to 1.00).
Discussion
The management of ethanol, opioid, benzodiazepine,
GHB and central stimulant poisoning is well established
[16–22]. There has been some controversy about how
long patients need observation, especially patients
treated with naloxone for opioid overdose. Christenson
et al. developed a set of criteria for discharging patients
one hour after naloxone administration [6]. However, re-
currence of respiratory depression in poisoning with
long acting opioids may occur outside this time frame,
and current practice at the OAEOC is based on a review
Fig. 1 Re-presentations during the first week following discharge from the Oslo Accident and Emergency Outpatient Clinic
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by Clarke et al. recommending an observation time of
two hours [23].
Patients observed at the OAEOC are hospitalised if
they do not regain full consciousness within 4 h. The
4-h limit was set as patients poisoned by ethanol or
heroin, the two most frequent toxic agents, should be
awake and recovering by this time. If not awake or if
confusion persists, other conditions must be suspected,
most of them beyond the scope of what can be managed
in the outpatient setting [15, 16, 24].
The three patients re-presenting increasingly somno-
lent seem to have been discharged too early. Even
though one of them was observed for five and a half
hours and was alert at discharge, he was somnolent one
hour later. They were all discharged into someone’s cus-
tody. Psychotic symptoms during the initial observation
may have been masked by heroin in the two patients re-
presenting with psychosis. The self-discharging patients
were advised to stay for further observation, unless they
left without notice. The haemorrhagic gastritis and the
minor injuries were overlooked.
The observational chart (Table 1) is not a treatment
algorithm, but more of a checklist for the clinical
examination of patients with suspected acute poison-
ing by substances of abuse. Other monitoring systems,
like the Rapid Emergency Triage and Treatment Sys-
tem (RETTS) [25] and the modified Early Warning
Score (MEWS) [26], could have been applied. How-
ever, the locally developed procedure has the advan-
tage of being specifically tailored for patients with
suspected acute poisoning by substances of abuse. In
addition, supervision is close, with repeated observa-
tions every 15–30 min, to identify patients whose
condition is deteriorating.
Though figures are not available, the treatment of pa-
tients with acute poisoning by substances of abuse at the
OAEOC is probably less expensive than in hospital
emergency departments. The observation time is short,
Table 3 Patients with missed diagnoses at index episode
Patient gender
and age




Toxic agents at indexa Treatment, disposition
and observation time
(hours:minutes) at index
M 38 Increasingly somnolent from
same poisoning, probably also
long-acting opioid, concomitant
compartment syndrome
4 days in medical
department




M 47 Brought back for same poisoning Outpatient at the
OAEOC
1 ½ hours Ethanol Self-discharged 0:45
F 21 Brought back for same poisoning Outpatient at the
OAEOC
3 h Ethanol, fluoxetine Self-discharged 1:00
M 14 Increasingly somnolent from
same poisoning
2 days in pediatric
department
3 h Heroin, benzodiazepines Discharged to Child
Welfare Services 2:10
F 40 Psychosis 7 days in psychiatric
ward
Same day Heroin, amphetamine Discharged, no
follow-up 8:15
M 34 Psychosis 4 days in psychiatric
ward
Same day Heroin Referred to psychiatric
outpatient clinic 5:40
F 28 Concussion, sprained ankle Outpatient at the
OAEOC
Same day Ethanol Discharged, no
follow-up 5:55
M 29 Contusions Outpatient at the
OAEOC
Same day Ethanol, amphetamine Discharged, no
follow-up 4:15
M 21 Increasingly somnolent, possibly
from same poisoning, if so also
with sedatives
1 day in medical
department
Next dayb Ethanol Discharged to police
custody 0:45
M 20 Concussion, contusions Outpatient at the
OAEOC
Next day Ethanol Discharged to Emergency
Social Services 4:10
F 49 Haemorrhagic gastritis 5 days in medical
department
2nd day Ethanol Referred to social
services 10:35




3rd day Ethanol Discharged, no
follow-up 6:05
M 44 Fracture of elbow and wrist 5 days in surgical
department
4th day Ethanol, cannabis Self-discharged 2:15
OAEOC Oslo Accident and Emergency Outpatient Clinic
aAll were accidental overdoses with substances of abuse
bAt least 18 h later
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with three out of four patients staying less than five and
a half hours, and fewer supplementary investigations are
done. In addition, outpatient treatment at the OAEOC
means less crowding in Oslo hospital emergency depart-
ments, allowing them to focus their resources on the
more severely sick patients.
In our study, less than one percent of nearly 2000
discharges needed further treatment for the same poi-
soning or had a missed diagnosis. Two patients died
from a new overdose within one week. In two previ-
ous 1-year studies of acute poisoning at the OAEOC,
in 2003 and 2008, the same methods were used, ex-
cept that re-presentations were not traced [10, 11]. In
2008, among 1865 discharges, nine patients died dur-
ing the first month; one from possible recurrence of
opioid toxicity, one committed suicide, five died of a
new overdose, and two from unrelated causes [10]. In
2003, among 801 discharges, no patients died during
the first week [11]. No patients with poisoning died
at the OAEOC in any of the studies. In our study,
one patient hospitalised from the OAEOC died in
hospital. During the two previous study periods, a
total of 14 patients died in Oslo hospitals from acute
poisoning by substances of abuse [27, 28]. We do not
know whether these patients were brought directly to
hospital by ambulance, or if any of the in-hospital fa-
talities could have been precipitated by delay at the
OAEOC. Furthermore, there are uncertainties con-
cerning the fate of the excluded patients in our study.
Still, it is our opinion that the results of the three
studies justify considering the observational procedure
at the OAEOC to be safe enough.
The deaths from new overdoses shortly after dis-
charge, and the high number of new non-fatal over-
doses, are signs of hazardous substance use among
these patients. This is in line with other studies show-
ing that an acute poisoning is a major risk factor for
new poisoning and death [29–31]. Consequently, the
acute poisoning episode would seem a suitable time
for intervention, e.g. brief interventions before dis-
charge, ensuring follow-up by general practitioner,
and/or referral to the specialist health services. Still,
during the study period, 36 % of the patients treated
Table 4 Specific treatment given at the OAEOC
Total n (%) Hospitalised n (%)
Medical treatment 402 (17) 103 (26)
Naloxone 198 (8) 48 (24)
Paracetamol 57 (2) 10 (18)
Thiamine 52 (2) 11 (21)
Intravenous fluids 51 (2) 17 (33)
Valproate 42 (2) 8 (19)
Alimemazine 32 (1) 6 (19)
Oxygen 30 (1) 20 (67)
Diazepam 21 (1) 14 (67)
Nitrazepam 19 (1) 5 (26)
Metoclopramide 16 (1) 2 (13)
Haloperidol 15 (1) 5 (33)
Active charcoal 8 (<1) 3 (38)
Flumazenil 3 (<1) 2 (67)
Resuscitated at the OAEOC 1 (<1) 1 (100)
Other 82 (3) 21 (26)
Departments involved besides the emergency general practice service
Trauma clinic 223 (10) 28 (13)
Psychiatric emergency service 64 (3) 8 (13)
Emergency social services 500 (21) 11 (2)
24 h observation unit 102 (4) 17 (17)
Total 2343 (100) 391 (17)
OAEOC Oslo Accident and Emergency Outpatient Clinic
Table 5 Reasons for hospitalisation, and diagnoses at hospital
Reason given for hospitalisation by physician at the OAEOC







Poisoning 171 (83) 2 (20) 27 (34) 25 (45) 63 (56) 236 (60)a
Injury - 7 (70) 5 (6) - 3 (3) 14 (4)a
Infection 6 (3) - 13 (16) 1 (2) 5 (4) 21 (5)a
Other somatic 17 (8) 1 (10) 25 (31) 2 (4) 20 (18) 57 (15)a
Psychiatric 11 (5) - 2 (3) 14 (25) 5 (4) 27 (7)a
Substance abuse 11 (5) 1 (10) 10 (13) 12 (21) 14 (12) 41 (10)a
Did not present - - - 4 (7) 4 (4) 8 (2)a
Total 206 (100)a 10 (100)a 80 (100)a 56 (100)a 113 (100)a 391 (100)a
OAEOC Oslo Accident and Emergency Outpatient Clinic
aNumbers and percentages may add up to more than total (100) as some patients were hospitalised for several reasons and some received more than one
diagnosis at the hospital
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for acute poisoning were discharged without follow-
up, an additional 13 % self-discharged [12].
Strengths and limitations
Our study encompassed the vast majority of patients with
acute poisoning by substances of abuse treated at the
OAEOC. The consecutive inclusion and the systematic
searches in the electronic patient lists ensured the inclu-
sion of practically all the eligible patients. In addition to
the 174 patients without a Norwegian national identity
number, 216 patients declined to participate. We do not
think these patients differ from the included patients in
ways that would have an impact on our main results.
The patients’ unique Norwegian national identity
number allowed us to track re-presentations at hospitals
nation-wide. Other casualty clinics in or around Oslo do
not treat acute poisoning to any significant extent. How-
ever, in 2003, 721 patients were left on scene after treat-
ment by the ambulance service in Oslo, among them
367 given naloxone for opioid poisoning [11]. We be-
lieve the figures to have been in the same range in 2012.
Unfortunately, we did not have access to the ambulance
medical records. Thus, we probably missed some re-
presentations among patients only treated by the ambu-
lance service the first week following discharge. Still, any
fatalities and patients with conditions severe enough to
be in need of treatment at the OAEOC or a hospital,
would show up in our data.
In 2008, nearly 200 patients with accidental overdoses
with substances of abuse bypassed the OAEOC and were
brought directly to hospital by the ambulance service
due to the severity of the poisoning [10, 28]. We expect
that these patients would have been sent on to hospital
had they been brought to the OAEOC.
Diagnosis of toxic agents was based on self-report and
clinical examination. No laboratory confirmation was done.
While we do not know which toxic agents our patients had
taken, the categories in our study refer to toxidromes that
to some extent are clinically distinguishable. It is likely that
new psychoactive substances may have been diagnosed as
amphetamine or cannabis [12]. The clinical picture often
associated with GHB poisoning, with fluctuating level of
consciousness and intermittent agitation, may also be the
result of a mixture of central stimulants and central de-
pressants. Furthermore, a Danish study sampling blood
from patients with heroin overdose, found that nearly all
the patients had taken a variety of additional substances of
abuse [32]. Still, our results are based on diagnoses and de-
cisions made in a real clinical situation. We think this adds
value to their generalizability. It also reflects current best
practice in toxicology in which patients are managed based
on clinical assessment. In most cases, treatment decisions
have to be made before reliable laboratory confirmation is
available. Along these lines, we found that the patient’s
clinical condition had greater impact on hospitalisation
than which toxic agents were diagnosed, as odds ratios for
hospitalisation were greater in the multivariate than in the
univariate analysis for several clinical observations and for
suicidal intent, while for toxic agents, except GHB, they
were smaller (Table 2).
Conclusion
We consider the OAEOC procedure for the clinical as-
sessment of acute poisoning by substances of abuse to
be safe enough. It may be implemented elsewhere. The
information gathered on the observational chart gives
clinicians the necessary basis for deciding whether the
patient can either be discharged, stay for observation or
requires treatment or further investigations, locally or at
hospital level. The high re-presentation rate during the
first week—mostly due to a new poisoning—calls for
better follow-up.
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